The Global Angiotensin Converting Enzymes (ACE) Inhibitors Market was valued at USD 8.08 Billion in 2023 and is projected to reach USD 12.6 Billion by 2031, growing at a CAGR of 5.7% from 2024 to 2031. ACE inhibitors are a class of medications primarily used to treat hypertension, heart failure, and chronic kidney disease. By blocking the enzyme that produces angiotensin II, ACE inhibitors help relax blood vessels, lower blood pressure, and reduce the workload on the heart. This market is driven by the increasing prevalence of cardiovascular diseases, advancements in pharmaceutical research, and the availability of generic drugs. Key players in the market include Novartis, Pfizer, Merck, AstraZeneca, and Sanofi.

Angiotensin Converting Enzyme (ACE) inhibitors are a class of medications primarily used to treat high blood pressure (hypertension) and heart-related conditions. They work by inhibiting the enzyme that produces angiotensin II, a substance in the body that narrows blood vessels and releases hormones that can raise blood pressure. By blocking the production of angiotensin II, ACE inhibitors help to relax blood vessels, lower blood pressure, and decrease the workload on the heart.

Here are some common uses of ACE Inhibitors:

• Hypertension (High Blood Pressure): ACE inhibitors are often prescribed to lower high blood pressure, which can reduce the risk of strokes, heart attacks, and kidney problems.
• Heart Failure: These medications are used to manage heart failure by reducing the strain on the heart and helping it pump more efficiently.
• Chronic Kidney Disease: ACE inhibitors can slow the progression of kidney disease, particularly in patients with diabetes, by reducing proteinuria (excess protein in the urine).
• Post-Heart Attack: After a heart attack, ACE inhibitors may be used to improve survival rates and prevent further heart damage.
• Diabetic Nephropathy: In patients with diabetes, ACE inhibitors can help protect the kidneys from damage due to high blood sugar levels.

Market Overview

The Global Angiotensin Converting Enzyme (ACE) Inhibitors Market was valued at USD 8.08 Billion in 2023 and is estimated to reach at USD 12.6 Billion in 2031 growing at a CAGR of 5.7% over the forecast period from 2024-2031. The report would provide you with market size estimates both in terms of revenue (USD Million) and volume (Million Units) for the time period from 2022 to 2031. The report would provide various factors responsible for growth of the market across various geographies considered under the scope of the study. The report covers in-depth global and regional level analysis of various market segmentations based on Type, Application, and Region.

Market Dynamics:

Below are the factors impacting the growth of Angiotensin Converting Enzyme (ACE) Inhibitors Market:

• Prevalence of Cardiovascular Diseases
  • Rising Hypertension Rates: The increasing prevalence of hypertension globally drives the demand for ACE inhibitors, as these medications are commonly prescribed to manage high blood pressure.
  • Aging Population: As populations age, the incidence of cardiovascular diseases, including hypertension and heart failure, rises, increasing the need for ACE inhibitors.
• Advancements in Healthcare and Pharmaceuticals
  • New Drug Developments: Ongoing research and development of new ACE inhibitors and combination therapies can drive market growth. Innovations that improve efficacy or reduce side effects can attract more patients and healthcare providers.
  • Generic Drug Availability: The availability of generic versions of ACE inhibitors has made these medications more accessible and affordable, contributing to market growth. However, it also impacts the profitability of branded drugs.
• Regulatory and Market Dynamics
  • Regulatory Approvals and Guidelines: Regulatory approvals for new ACE inhibitors and updated treatment guidelines can impact market growth. Approval from agencies like the FDA and EMA can lead to wider adoption and use.
  • Patent Expirations: The expiration of patents for key ACE inhibitors allows the entry of generic drugs, which can lower prices and expand market reach. However, it also reduces revenue for original patent holders.

 Regional Analysis

Based on region, Global Angiotensin Converting Enzyme (ACE) Inhibitors Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America is divided into United States, Canada, and Mexico. Europe is bifurcated into Germany, U.K., France, Italy, Spain and Rest of Europe. The key country covered under Asia Pacific region includes China, Japan, India, South East Asia and Rest of Asia Pacific. Middle East & Africa is bifurcated into UAE, Saudi Arabia, South Africa and Rest of MEA. Finally, Latin America is divided into Brazil, Argentina and Rest of Latin America.

Competition Landscape

The report covers company profiles and competition analysis of major players operating under Global Angiotensin Converting Enzyme (ACE) Inhibitors Market. The company profile section includes Company Overview, Financials, Business Overview, Recent Developments, Key Strategies, Product Mapping, Regional Presence, etc. Further, the competition analysis provides you with details about Competitor Overview, Market Share Analysis, Company Performance based on Various Parameters, etc. The major players operating in Global Angiotensin Converting Enzyme (ACE) Inhibitors Market  are Novartis AG, Pfizer, Inc, Merck & Co., Inc., Bristol Myers Squibb, Astra and Zeneca, UCB (Schwarz Pharma Inc.), Solvay Pharmaceuticals B.V., Abbott, Endo International (Par Pharmaceutical, Inc.), and Sanofi.

 Market Segmentation

The Global Angiotensin Converting Enzyme (ACE) Inhibitors Market can be segmented on the basis of Type, Application, and Region. Further, the report would provide a detailed analysis based on below mentioned market segmentation at the global as well regional levels.

 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Scope:

 Global Angiotensin Converting Enzyme (ACE) Inhibitors Market, By Region and Countries:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South East Asia
  • Rest of Asia Pacific
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
• South America
  • Brazil
  • Argentina
  • Rest of South America

 Reason to Purchase the Report:

• Latest trends in the market
• In depth market segmentation and cross regional / country analysis
• Market dynamics analysis including drivers, restraints and opportunities in the market
• Market sizing and segment analysis
• Competition Analysis including profiling of key market players
• Market share analysis and key strategies adopted by key players
• Recent developments and technological advancement by key players in the market
• Key takeaways from the research findings to take strategic decision in business needs